Algernon Pharmaceuticals Inc.
AGNPF
$0.0488
-$0.0022-4.31%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 214.80K | -272.30K | -377.30K | -1.97M | -3.86M |
| Total Depreciation and Amortization | 16.60K | 18.10K | 19.50K | 25.60K | 30.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.32M | -1.23M | -1.19M | 60.60K | 1.57M |
| Change in Net Operating Assets | -1.04M | -664.60K | -467.00K | -98.80K | 1.05M |
| Cash from Operations | -2.12M | -2.15M | -2.01M | -1.98M | -1.21M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.68M | 1.69M | 1.69M | 1.69M | -19.90K |
| Cash from Investing | 1.68M | 1.69M | 1.69M | 1.69M | -19.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 349.30K | 614.90K | 614.70K | 370.80K | 1.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 286.50K | 286.50K | 286.50K | 171.40K | 91.20K |
| Cash from Financing | 464.30K | 662.00K | 661.80K | 405.20K | 1.12M |
| Foreign Exchange rate Adjustments | 3.00K | 2.80K | -200.00 | 3.30K | -300.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.70K | 210.00K | 345.90K | 123.60K | -110.20K |